Archive
All News
Every briefing, headline, and filing we've published, newest first.
PipelineFierceBiotech ↗
Regenxbio’s gene therapy for Duchenne muscular dystrophy has smashed the primary endpoint of its pivotal trial…
PipelineFiercePharma ↗
BeOne Medicines has entered the BCL-2 arena, securing an FDA green light for Beqalzi that carves out a unique …
DealsBriefing
Taiwan’s Bora Group is buying MacroGenics’ Maryland CDMO operations, adding a 20,000‑liter biologics capacity …
PolicySTAT News ↗
The Justice Department sent a letter to Yale School of Medicine on Thursday, alleging it was illegally discrim…
PolicyEndpoints News ↗
The Supreme Court will continue to allow the abortion pill mifepristone to be distributed by mail, at least fo…
The WeekDrug Channels ↗
Today’s guest post comes from Peter Darch, SVP of Strategy and Operations at PHIL Inc. Peter explains that gro…
PolicySTAT News ↗
The Supreme Court on Thursday preserved women’s access to the abortion drug mifepristone, rejecting lower-cour…
PolicyKFF Health News ↗
On May 22, the House passed a reconciliation bill, the One Big Beautiful Bill Act, which would partially pay t…
PipelineEndpoints News ↗
A gene therapy designed by Encoded Therapeutics reduced seizures by 76% in children with Dravet syndrome, a se…
PolicyKFF Health News ↗
State-by-state information on Medicaid 1115 work requirement waivers.…
PolicyPharmaVoice ↗
During Dr. Martin Makary’s tenure as commissioner, the FDA faced pushback over high-profile drug rejecti…
DealsPharmaceutical Technology ↗
Zydus Lifesciences is set to acquire all outstanding Assertio common shares in a $166.4m deal, via its subsidi…
PipelineFiercePharma ↗
Eli Lilly and Novo Nordisk are building cases for their incretin drugs, both new and old, as attractive weight…
DealsFierceBiotech ↗
Novo Nordisk has found the latest buyer for one of its orphaned cell therapies.…
PolicyBriefing
With Roe overturned, state and federal courts are becoming the frontline in defining access to abortion and co…
PolicyKFF Health News ↗
This brief examines recent state trends in Medicaid behavioral health coverage and payment and state coverage …
PipelineSTAT News ↗
The case for Makary as the WOAT, Cassidy's seat at risk ahead of midterms, and other biotech news from The Rea…
PeopleFiercePharma ↗
Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending a brief but tumultuous tenure marked by m…
MoneyFierceBiotech ↗
If any proof was needed that big money is still available for AI drug development, look no further than the 10…
PipelineBriefing
Three months post-Avadel acquisition, Alkermes’ Lumryz met all endpoints in the phase 3 Revitalyz study for id…
The WeekDrug Channels ↗
By Bryce Platt, PharmD The onslaught of pharmacy-related news doesn’t end. It may even be increasing in volume…
PipelineSTAT News ↗
Doctors have linked a boy's tumor to a gene therapy, but say the rare risks need to be weighed against the pro…
DealsEndpoints News ↗
Bayer is back on the market for drug acquisitions after a half-decade on the sidelines, according to CEO Bill …
PipelinePharmaceutical Technology ↗
An indirect comparison highlights the potential of BridgeBio's Attruby to best Pfizer’s tafamidis in frontline…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.